Post Categories
Blog post not found!
Equine Coronavirus and Horses’ Contribution to the COVID-19 Vaccine
March 29, 2021
Since the outbreak of the COVID-19 pandemic, people around the world have been asked to do their part to prevent the virus from spreading….
Determining “Responsible Clinical Use” in Heritable Human Genome Editing
March 22, 2021
A common refrain in science fiction movies is the cautionary statement, “Just because we can doesn’t mean we should.” As new technologies such as…
View from My Window, Part 3: The Community We Build
March 15, 2021
In January, we introduced the social media phenomenon “View From My Window” (VFMW), a Facebook Group whose members who have posted pictures of their…
COVID-19 Immunity After Infection: Can You Catch COVID-19 Twice?
March 10, 2021
After recovering from a viral infection, the human body’s immune system retains a memory of the virus so that if the person encounters it…
A COVID-19 Call to Arms: The HHS Invites Everyone to Join the Fight
March 8, 2021
The U.S. Department of Health and Human Services recently launched a new website to enlist the public’s support in fighting the SARS-CoV-2 virus: CombatCovid.hhs.gov….
Robust Cell and Gene Therapy Pipeline Targets a Range of Diseases
March 1, 2021
Cell and gene therapies (CGTs) are quickly making their way from theory to clinical practice, primarily because they target specific disease drivers rather than…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
